Published by Iain Gilbert on 14th December 2022
(Sharecast News) - Gene and cell therapy company Oxford Biomedica has struck agreements with three US biotechnology companies, bringing the firm's total number of new adeno-associated virus customers in 2022 to four.
URL: http://www.digitallook.com/dl/news/story/33177095/...